Romania
Tuberculosis profile
Population  2012 22 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 1.2 (1.2–1.2) 5.6 (5.5–5.6)
Mortality (HIV+TB only) 0.1 (0.088–0.13) 0.48 (0.4–0.6)
Prevalence  (includes HIV+TB) 31 (15–55) 144 (67–251)
Incidence  (includes HIV+TB) 20 (17–24) 94 (77–112)
Incidence (HIV+TB only) 0.6 (0.49–0.72) 2.8 (2.3–3.3)
Case detection, all forms (%) 79 (66–96)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 6 987 (50) Relapse 2 219 (51)
Smear-negative 4 224 (30) Treatment after failure 663 (15)
Smear-unknown / not done 205 (1) Treatment after default 570 (13)
Extrapulmonary 2 472 (18) Other 857 (20)
Other 0 (0)      
Total new 13 888   Total retreatment 4 309  
           
Other (history unknown) 0        
Total new and relapse 16 107   Total cases notified 18 197  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.4 1.6 1.3
Age < 15 36 205 472
Laboratories 2012
Smear (per 100 000 population) 0.5
Culture (per 5 million population) 20.9
Drug susceptibility testing (per 5 million population) 9.9
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 86   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 86  
Retreatment 59  
TB/HIV 2012 Number (%)
TB patients with known HIV status 9 699 (53)
HIV-positive TB patients 229 (2)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 174 (76)
HIV-positive TB patients on antiretroviral therapy (ART) 205 (90)
HIV-positive people screened for TB    
HIV-positive people provided with IPT 174  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.8 (1.8–4.2) 11 (8–15)
MDR-TB cases among notified pulmonary
TB cases
320 (210–480) 470 (350–630)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 3 944 (43%) 2 022 (47%) 5 966
Laboratory-confirmed MDR-TB cases 114 416 530
Patients started on MDR-TB treatment     729
Financing TB control 2013
National TB programme budget (US$ millions) 24
% Funded domestically 32%
% Funded internationally 10%
% Unfunded 59%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data